Aun Consulting
2459
Welby
4438
Value Creation
9238
Perseus Proteomics
4882
DMS
9782
JP Stock MarketDetailed Quotes
6857 Advantest
- 8283.0
- -421.0-4.84%
20min DelayMarket Closed Mar 19 15:30 JST
6.35TMarket Cap98.42P/E (Static)
8499.0High8283.0Low13.29MVolume8471.0Open8704.0Pre Close111.40BTurnover10430.052wk High1.83%Turnover Ratio766.14MShares4952.052wk Low184.17EPS TTM6.02TFloat Cap10430.0Historical High98.42P/E (Static)726.93MShs Float167.8Historical Low84.16EPS LYR2.48%Amplitude37.00Dividend TTM12.23P/B100Lot Size0.45%Div YieldTTM
Advantest News
Advantest: Status of Share Repurchase and its Completion
Advantest: FY2024 3Q Financial Briefing
Advantest: Revisions of Year-End Dividends Forecast
Advantest: FY2024 Third Quarter Consolidated Financial Results
Advantest: Revision of Earnings Forecast for the Fiscal Year Ending March 31, 2025
Advantest: Status of Share Repurchase
Advantest: Status of Share Repurchase
Advantest: Semi-Annual Securities Report (FY2024)
Advantest: FY2024 2Q Financial Briefing
Advantest: FY2024 Second Quarter (Semi-Annual) Consolidated Financial Results
Advantest: Share Repurchase
Advantest: Interim Dividends for the Fiscal Year Ending March 31, 2025
Advantest: Integrated Annual Report 2024 (2/2)
Advantest: Integrated Annual Report 2024 (1/2)
Advantest: Integrated Report 2024 (2/2)
Advantest: Integrated Report 2024 (1/2)
Advantest: FY 2024 Q1 Financial Results Briefing
Advantest: Consolidated financial results for the first quarter of fiscal year 2024.
Advantest: Revision of dividend financial estimates
Advantest: Revision of financial estimates for the business year ending on March 31, 2025.
